The Absolute Best Canadian Stocks to Buy and Hold Forever in a TFSA

The TFSA is the perfect place to hold Canadian stocks that will compound and multiply over decades. These stocks are a great TFSA fit.

| More on:
cloud computing

Source: Getty Images

The TFSA (Tax-Free Savings Account) is a completely tax-free savings and investing account (the name pretty much says it all). You don’t pay tax on any income (capital gains, interest, or dividends) earned and you don’t pay any tax when you withdraw from the account.

Some bank advisors recommend putting dividends and interest-bearing investments in the TFSA. That is because those types of income have the highest tax rates. Capital gains earn the lowest tax rate.

Use the TFSA for your biggest potential winners

However, you need to use the TFSA for its total tax savings. The way you get the most tax savings is by owning stocks that create substantial capital gains by compounding and multiplying in value.

You don’t want to pay any tax on a $100,000-plus gain (or any gain for that matter). If you hit the right stock, a 20, 50, or even 100 times return is possible. It only takes one or two of those stocks to make life-changing returns.

Don’t split any of those gains with the government. Instead, put the best stocks in the best companies in your TFSA. Here are three Canadian stocks that are perfect for tucking into your TFSA and holding just about forever.

A small cap tech stock for a long-term TFSA hold

With a market cap of $530 million, VitalHub (TSX:VHI) is still in its early days of growth. The company had a great run in 2024. It rose over 170% last year.

Since the start of the year, VHI has pulled back by over 12%. It is still a pricey stock at 22 times free cash flow, but its valuation is starting to look more attractive.

VitalHub is building out a strong portfolio of software solutions for the healthcare industry. If any industry is due for technological disruption, it is the healthcare industry. Health systems are incredibly stressed, understaffed, and underfunded.

VitalHub’s software can help alleviate these challenges around the world. This TFSA stock has a large market to grow into. With a strong balance sheet and ample acquisition opportunities, it could continue to deliver substantial returns ahead.

A growing North American insurance stock

With a market cap of $1.6 billion, Trisura Group (TSX:TSU) is an established business that could still grow significantly. This TFSA stock provides specialty and fronting insurance solutions in Canada and the United States.

It has spent the past few years building out the infrastructure to be an effective insurance provider in its core geographies. With its strategy defined, it is now ready to steadily grow into a substantial player in those markets.

The company has a great long-term track record. This stock has soared by 250% in the past five years. TSU has flatlined in recent history, but that has allowed its valuation to become attractive. It could be a great time to add to this TFSA stock today.

Hold this Canadian software stock for years

Even though Topicus.com (TSXV:TOI) has an $11.5 billion market cap, not many Canadians have heard of it before. This is largely because it has only been publicly listed for a couple of years. Also, the software firm operates through many small, focused software companies. Lastly, it operates mainly in Europe, so its software is largely unknown in Canada.

The company has a strong development platform, which has fueled mid-single-digit organic growth. The rest of the growth has come from making smart acquisitions around Europe. It recently announced some big strategic deals, and the market is starting to take notice.

This is a high-quality business perfect for a TFSA. Buy it, hold it, and let this stock compound tax-free inside a TFSA for the years and decades ahead.

Fool contributor Robin Brown has positions in Topicus.com, Trisura Group, and Vitalhub. The Motley Fool has positions in and recommends Topicus.com, Trisura Group, and Vitalhub. The Motley Fool has a disclosure policy.

More on Retirement

Canadian Red maple leaves seamless wallpaper pattern
Dividend Stocks

CRA Just Released New 2026 Tax Brackets

New 2026 CRA tax brackets can cut “bracket creep” so plan around them to ensure more compounding, and consider Manulife…

Read more »

monthly calendar with clock
Dividend Stocks

How to Use Your TFSA to Earn $700 per Month in Tax-Free Income

Turn your TFSA into a steady, tax‑free monthly paycheque, Here’s a simple plan and why APR.UN fits the bill.

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

How I’d Structure a $50,000 TFSA for Almost Constant Income

Turn a $50,000 TFSA into a dependable, tax‑free paycheque with a simple ETF mix. Here’s why VDY can anchor the…

Read more »

shopper pushes cart through grocery store
Dividend Stocks

The Canadian Dividend Stock I’d Trust for the Next Decade

This northern grocer could anchor a 10‑year dividend plan. Here’s why NWC’s essential markets and steady cash flows make it…

Read more »

Piggy bank with word TFSA for tax-free savings accounts.
Dividend Stocks

Here’s the Average TFSA Balance at Age 55 in Canada

Turning 55? See how a TFSA and a low‑volatility income ETF like ZPAY can boost tax‑free retirement cash flow while…

Read more »

View of high rise corporate buildings in the financial district of Toronto, Canada
Dividend Stocks

How to Use Your TFSA to Earn $275 in Monthly Tax-Free Income

Discover how True North Commercial REIT’s government‑anchored leases could help turn a TFSA into monthly, tax‑free income even amid a…

Read more »

Retirees sip their morning coffee outside.
Dividend Stocks

Top TSX Dividend Stocks for Retirees

Picking dividend stocks for retirees involves a different set of criteria compared to non-retirees. Here are some great picks to…

Read more »

doctor uses telehealth
Dividend Stocks

1 Magnificent Canadian Dividend Down 62% to Buy and Hold for Decades

This overlooked healthcare REIT may be turning the corner. Here’s why its beaten‑down price could reward patient, income‑focused investors.

Read more »